We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Nutrient Agar Substituted for Blood in Antibiograms

By LabMedica International staff writers
Posted on 17 Sep 2012
In laboratories in the developed world, blood agar plates are used to test antibiotic sensitivity of bacteria, but in resource poor laboratories, this may not be feasible.

Beta-hemolytic Streptococcus species also grow on Standard Nutrient Agar 1 (StNA1 and it has been suggested this type of nutrient medium could be used for running agar diffusion tests.

Bacteriologists at Globolab eV Laboratory (Assling, Germany) conducted 103 comparative tests to evaluate the growth characteristics of beta-hemolytic Streptococcus spp. More...
on StNA1 compared to Müller–Hinton agar supplemented with 5% sheep blood (B-MH). The specimens were obtained from patients admitted to a cooperating hospital in Germany and 16 beta-hemolytic streptococci strains were obtained.

Bacteria to be tested are streaked uniformly across a culture plate. Paper disks impregnated with eight different antibiotics (Oxoid; Wesel, Germany) to be tested are placed on the surface of the gelatinous agar. During incubation of the agar plate, the antibiotics diffuse from the disks into the surrounding agar. An effective agent will inhibit bacterial growth, and the size of such a zone of inhibition (ZoI) around the disk is measured. The relative effectiveness of a compound is determined by comparing the diameter of the ZoI with values in standard tables.

The authors found that found in 99 out of 103 (96.12%) of all cases that the absolute values of ZoI differences were smaller than or equal to 3 mm, and 92 out of 103 (89.32%) were smaller than or equal to 2 mm. The Standard Nutrient Agar 1 (StNA1) is marketed by Carl Roth GmbH (Karlsruhe, Germany) can be used for culturing Enterobacteriaceae, Pseudomonas spp., Staphylococcus spp., and Streptococcus spp. The B-MH used in the study was obtained from bioMérieux (Marcy l'Etoile, France).

The authors concluded that although blood agar is always the better choice for several reasons, the reading of the ZoI is often easier on StNA1 than on B-MH. This is because StNA1 is more transparent and, therefore, the edges between bacterial growth and the inhibition zone can be discerned more easily. In such places where no blood agar is available for conducting antibiograms, StNA1 is an appropriate substitute for blood-supplemented Müller–Hinton agar. The study was published on August 29, 2012, in the European Journal of Clinical Microbiology & Infectious Diseases.

Related Links:

Globolab e.V. Laboratory
Oxoid
Carl Roth GmbH




Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Serological Pipet Controller
PIPETBOY GENIUS
New
Urine Drug Test
Instant-view® Phencyclidine Urine Drug Test
New
Vasculitis Diagnostic Test
AESKULISA Vasculitis-Screen
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Ear wax could be a possible screening medium for Parkinson’s disease (Photo courtesy of 123RF)

Earwax Test Accurately Detects Parkinson’s by Identifying Odor Molecules

Current tests for Parkinson’s disease (PD) rely heavily on clinical scales and neuroimaging, which are often subjective, expensive, and ill-suited for routine screening. Since most treatments only slow... Read more

Molecular Diagnostics

view channel
Image: A family of molecules could help diagnose and treat breast cancer (Photo courtesy of Shutterstock)

Molecular Biomarkers Pave Way for New Tests to Diagnose and Predict Breast Cancer

Despite playing essential roles in tissue development and immune protection, the contribution of proteoglycans in cancer remains poorly understood. Some proteoglycans appear to shield the body from cancer,... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: T cell immunity could be a marker for early Parkinson’s treatment (Photo courtesy of Shutterstock)

T Cells in Blood Can Detect Parkinson's Years Before Diagnosis

Diagnosing Parkinson’s disease before the appearance of motor symptoms remains one of neurology’s most significant challenges. Patients can go years—even decades—without a diagnosis, as subtle early indicators... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.